Predictive value of ACEF II score for adverse prognosis in patients with coronary heart disease after percutaneous coronary intervention

医学 传统PCI 经皮冠状动脉介入治疗 内科学 心脏病学 射血分数 比例危险模型 接收机工作特性 弗雷明翰风险评分 心肌梗塞 心力衰竭 疾病
作者
Siyi Wu,Zhiqing Qiu,Yaqiong Lu,Xiaoguang Wu,Ting Gao,Jie Xu,Shuangshuang Li,Xiang Zhou
出处
期刊:Postgraduate Medical Journal [Oxford University Press]
卷期号:99 (1172): 605-612 被引量:2
标识
DOI:10.1136/postgradmedj-2022-141609
摘要

To investigate the predictive value of age, creatinine and ejection fraction (ACEF) II score for the incidence of major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI).A total of 445 patients with CHD who underwent PCI were consecutively enrolled. The receiver operating characteristic (ROC) curve was used to analyse the power of the ACEF II score in predicting MACCE. Kaplan-Meier survival curves and log-rank tests were chosen for survival analysis of adverse prognosis between groups. Finally, multivariate Cox proportional risk regression analysis was used to investigate independent risk factors for MACCEs in patients with CHD after PCI.There was a significantly higher incidence of MACCEs in patients with high ACEF II scores. The area under the ROC curve of ACEF II score was 0.718, suggesting it had ideal predictive value for MACCE risks. The ACEF II score had a best cut-off value of 1.461 (sensitivity 79.4%, specificity 53.7%). Survival analysis indicated that patients in the high-score group had a significantly lower cumulative MACCE-free survival rate. Multivariate Cox regression analysis showed that ACEF II scores ≥1.461, Gensini scores ≥61.5, age, cardiac troponin I and previous PCI were independent risk factors of MACCE in patients with CHD after PCI, while the utilisation of statins was an independent protective factor.The ACEF II score has an ideal capacity for risk stratification in patients with CHD undergoing PCI and offers good predictive value for MACCE in the long term.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
温婉的凝丹完成签到 ,获得积分10
1秒前
s橙子味日出_关注了科研通微信公众号
2秒前
4秒前
啊啊完成签到,获得积分10
9秒前
9秒前
donghai发布了新的文献求助10
11秒前
李健应助Ca采纳,获得10
11秒前
hhh发布了新的文献求助10
12秒前
15秒前
orixero应助啦啦啦采纳,获得10
15秒前
zrs发布了新的文献求助10
17秒前
18秒前
阎万怨完成签到 ,获得积分10
19秒前
大模型应助Pepsi采纳,获得10
20秒前
ZW发布了新的文献求助10
20秒前
听话的蜡烛完成签到,获得积分10
21秒前
21秒前
seven发布了新的文献求助10
23秒前
hhh完成签到,获得积分10
24秒前
眼睛大智宸完成签到,获得积分10
25秒前
白夜完成签到 ,获得积分10
26秒前
研友_89Nm7L发布了新的文献求助10
26秒前
陈醋塔塔完成签到,获得积分10
26秒前
852应助zrs采纳,获得10
28秒前
29秒前
moufei完成签到,获得积分10
29秒前
芝士大王完成签到 ,获得积分10
29秒前
修辛发布了新的文献求助10
30秒前
亲亲完成签到,获得积分10
30秒前
ccCherub完成签到,获得积分10
30秒前
CrsCrsCrs完成签到,获得积分10
32秒前
moufei发布了新的文献求助10
35秒前
NexusExplorer应助潇潇雨歇采纳,获得10
35秒前
椿人完成签到 ,获得积分10
37秒前
陈陈陈完成签到 ,获得积分10
39秒前
39秒前
40秒前
MaYue发布了新的文献求助10
42秒前
45秒前
四夕完成签到 ,获得积分10
47秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Fashion Brand Visual Design Strategy Based on Value Co-creation 350
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777911
求助须知:如何正确求助?哪些是违规求助? 3323444
关于积分的说明 10214462
捐赠科研通 3038671
什么是DOI,文献DOI怎么找? 1667606
邀请新用户注册赠送积分活动 798207
科研通“疑难数据库(出版商)”最低求助积分说明 758304